ALB and cancer: The mSIS is an emerging tool for evaluating overall inflammatory status in various diseases, including cardiovascular conditions, cancers, and potentially, AMD.[7,19,20] The evidence provided by Chang et al[9] in renal cell carcinoma cases indicated that serum albumin levels and LMR are independent prognostic markers according to their multivariate analysis.